Total Visits

Views
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer8

Total Visits Per Month

July 2021August 2021September 2021October 2021November 2021December 2021January 2022
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer0014120

File Downloads

Views
41467_2020_18636_MOESM3_ESM.pdf6
41467_2020_18636_MOESM1_ESM.pdf5
41467_2020_Article_18636_nlm.xml1
41467_2020_Article_18636.pdf1
41467_2020_18636_MOESM2_ESM.pdf1

Top country views

Views
United States6
United Kingdom2

Top cities views

Views
Ashburn2
Cambridge2